Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

MAIT cell subtypes in multiple sclerosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibodies to Epstein-Barr virus and neurotropic viruses in multiple sclerosis and optic neuritis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Expression of melanoma cell adhesion molecule-1 (MCAM-1) in natalizumab-treated multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. B cells from patients with multiple sclerosis have a pathogenic phenotype and increased LTα and TGFβ1 response

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Dimethyl Fumarate Treatment in Patients With Primary Progressive Multiple Sclerosis: A Randomized, Controlled Trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exposure to passive smoking during adolescence is associated with an increased risk of developing multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Treatment- and population-specific genetic risk factors for anti-drug antibodies against interferon-beta: a GWAS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Biomarkers of inflammation and epithelial barrier function in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

In patients with multiple sclerosis (MS) and healthy controls (HC) we studied circulating MAIT cells and MAIT cell subtypes expressing CXCR3 and CCR6 by flow cytometry. Absolute numbers of MAIT cells and specifically Tc17-like MAIT cells were lower in patients with primary progressive MS (PPMS) than in controls. Low numbers of Tc17-like MAIT cells were associated with smoking and high concentrations of myelin basic protein in the cerebrospinal fluid. Treatment with alemtuzumab and dimethyl fumarate decreased MAIT cell frequencies. Altogether, we have identified specific MAIT cell subtypes related to PPMS, smoking and demyelination, and MAIT cell effects of MS therapies.

Original languageEnglish
Article number577117
JournalJournal of Neuroimmunology
Volume339
Pages (from-to)577117
ISSN0165-5728
DOIs
Publication statusPublished - 15 Feb 2020

    Research areas

  • Adult, Female, Humans, Immunosuppressive Agents/pharmacology, Male, Middle Aged, Mucosal-Associated Invariant T Cells/metabolism, Multiple Sclerosis, Chronic Progressive/blood, Multiple Sclerosis, Relapsing-Remitting/blood, Multiple Sclerosis/blood, Smoking/blood

ID: 59754035